Michael Downing, MD
Psychiatry · Dallas, TXNPI 1639159346
Payments from drug & device makers
Across 1,235 payments — averaging $6166.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sage Therapeutics, LLC$1.5M
- AbbVie$1.3M
- Axsome Therapeutics, Inc.$941K
- Sumitomo Pharma America, Inc.$652K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$644K
- Janssen Research & Development, LLC$452K
- plus $2.2M from 33 others
Across 36 payments — averaging $6103.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arbor Pharmaceuticals, Inc.$156K
- Pfizer$60K
- Eli Lilly$3K
- Supernus Pharmaceuticals, Inc.$1K
What the payments were for
- Food & beverage$3,51799%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$114
How this compares
$7,615,929 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega TrinzaPaliperidone Palmitate | 34 | $292,114 |
| VraylarCariprazine Hcl | 30 | $58,112 |
| AristadaAripiprazole Lauroxil | 11 | $34,161 |
| Lurasidone Hcl | 13 | $25,413 |
| Clozapine | 139 | $12,235 |
| BelsomraSuvorexant | 17 | $7,092 |
| ClozarilClozapine | 12 | $5,333 |
| Paliperidone ErPaliperidone | 22 | $4,260 |
| Divalproex Sodium ErDivalproex Sodium | 26 | $3,361 |
| Olanzapine | 50 | $2,851 |
| Aripiprazole | 24 | $2,376 |
| Fluvoxamine Maleate | 15 | $2,197 |
| Bupropion XlBupropion Hcl | 11 | $1,974 |
| Clonazepam | 73 | $1,117 |
| Lamotrigine | 35 | $729 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Trinza | $980 | $292,11434 claims |
| AbbVieVraylar | $1,250,738 | $58,11230 claims |
| Alkermes, Inc.Aristada | $329 | $34,16111 claims |
| MerckBelsomra | $9,265 | $7,09217 claims |
| Dr.reddy's Laboratories,inc.Lamotrigine | $3,046 | $72935 claims |
| Almatica Pharma LLCSertraline Hcl | $27 | $28223 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Dallas
- Scott BartleyDallas$42.7M
- Darin OkudaDallas$14.7M
- John PascoeDallas$2.3M
- Madhukar TrivediDallas$2.1M
- Manish JhaDallas$1.3M
- Mary KnesevichDallas$1.2M
- Seema GuptaDallas$1.2M
- Eric WilliamsDallas$976K
- Joel HolinerDallas$948K
- Augustus RushDallas$760K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.